Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism HDAC6 inhibitors(Histone deacetylase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC20H26N4O4 |
InChIKeyVTRGFHYHEAEHGS-UHFFFAOYSA-N |
CAS Registry2707431-93-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Preclinical | US | 20 Aug 2020 |